Moreover, epigallocatechin-3-gallate has been shown to decrease IGF1 and restore IGF binding protein 3 (IGFBP3) levels in hepatocellular carcinoma cells. The gene discussed is IGFBP3; the disease is hepatocellular carcinoma.